1 line
22 KiB
Plaintext
1 line
22 KiB
Plaintext
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T17:43:46Z","timestamp":1703094226344},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n <jats:title>Purpose<\/jats:title>\n <jats:p>To investigate whether compulsory face masking in public life changes the incidence or pattern of post-injection endophthalmitis (PIE).<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Patients and methods<\/jats:title>\n <jats:p>All injections of bevacizumab, ranibizumab, aflibercept, dexamethasone or triamcinolone between 01\/01\/2015 and 12\/31\/2021 at the University Eye Clinic of Tuebingen were included in this retrospective analysis. The injection procedure itself was unchanged since 2015 and included the use of a sterile drape covering the head up to the shoulders which prevents airflow toward the eye. Furthermore, all staff wore a face mask and gloves at all times. The two study periods were defined by the introduction of a compulsory face masking rule in public life (01\/01\/2015 until 04\/27\/2020 vs. 04\/28\/2020 until 12\/31\/2021).<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Results<\/jats:title>\n <jats:p>A total of 83,543 injections were performed in the tertiary eye clinic, associated with a total of 20 PIE (0.024%, 1\/4177 injections). Of these, thirteen PIE were documented during the pre-pandemic period (0.021%, 1\/4773 injections) and seven PIE during the pandemic period (0.033%, 1\/3071 injections). No significant difference in PIE risk was observed (<jats:italic>p<\/jats:italic>\u2009=\u20090.49), and there was no case of oral flora associated PIE.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Conclusion<\/jats:title>\n <jats:p>Although some potential confounders (wearing time, skin flora) could not be considered, there was no clear signal that the introduction of compulsory face masking in public life did alter the risk for PIE in our patient population. Three and six months after PIE, no difference in visual acuity was detectable between the two study periods.<\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s00417-022-05768-6","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T08:02:37Z","timestamp":1659772957000},"page":"97-102","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection"],"prefix":"10.1007","volume":"261","author":[{"ORCID":"http:\/\/orcid.org\/0000-0002-4120-534X","authenticated-orcid":false,"given":"Jonas","family":"Neubauer","sequence":"first","affiliation":[]},{"given":"Konstantinos","family":"Gklavas","sequence":"additional","affiliation":[]},{"given":"Friederike","family":"Kort\u00fcm","sequence":"additional","affiliation":[]},{"given":"Mariya","family":"Gosheva","sequence":"additional","affiliation":[]},{"given":"Karl Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[]},{"given":"Focke","family":"Ziemssen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"1","key":"5768_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajo.2015.04.013","volume":"160","author":"D Dossarps","year":"2015","unstructured":"Dossarps D, Bron AM, Koehrer P, Aho-Glele LS, Creuzot-Garcher C, net F (2015) Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol 160(1):17\u201325. https:\/\/doi.org\/10.1016\/j.ajo.2015.04.013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"5768_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/IAE.0B013E31822C2958","volume":"32","author":"RR Doshi","year":"2012","unstructured":"Doshi RR, Leng T, Fung AE (2012) Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 32(3):473\u2013476. https:\/\/doi.org\/10.1097\/IAE.0B013E31822C2958","journal-title":"Retina"},{"issue":"2","key":"5768_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/IAE.0000000000000694","volume":"36","author":"SJ Garg","year":"2016","unstructured":"Garg SJ, Dollin M, Storey P, Pitcher JD 3rd, Fang-Yen NH, Vander J, Hsu J, Post-Injection Endophthalmitis Study T (2016) Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy. Retina 36(2):351\u2013359. https:\/\/doi.org\/10.1097\/IAE.0000000000000694","journal-title":"Retina"},{"issue":"4","key":"5768_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","volume":"239","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Told R, Sacu S, Bandello F, Moisseiev E, Loewenstein A, Schmidt-Erfurth U, Euretina B (2018) 2018 Update on intravitreal injections: Euretina Expert Consensus Recommendations. Ophthalmologica 239(4):181\u2013193. https:\/\/doi.org\/10.1159\/000486145","journal-title":"Ophthalmologica"},{"issue":"8","key":"5768_CR5","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00417-013-2274-y","volume":"251","author":"H Shimada","year":"2013","unstructured":"Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M (2013) Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol 251(8):1885\u20131890. https:\/\/doi.org\/10.1007\/s00417-013-2274-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"5768_CR6","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1111\/aos.14904","volume":"100","author":"FC Kortuem","year":"2022","unstructured":"Kortuem FC, Ziemssen F, Kortuem KU, Kortuem C (2022) International survey on COVID-19 pandemic: personal protective measures during fundus examination. Acta Ophthalmol 100(1):e325\u2013e326. https:\/\/doi.org\/10.1111\/aos.14904","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"5768_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41591-020-0843-2","volume":"26","author":"NHL Leung","year":"2020","unstructured":"Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP, Yen HL, Li Y, Ip DKM, Peiris JSM, Seto WH, Leung GM, Milton DK, Cowling BJ (2020) Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 26(5):676\u2013680. https:\/\/doi.org\/10.1038\/s41591-020-0843-2","journal-title":"Nat Med"},{"issue":"3","key":"5768_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003205","volume":"9","author":"DK Milton","year":"2013","unstructured":"Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ (2013) Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog 9(3):e1003205. https:\/\/doi.org\/10.1371\/journal.ppat.1003205","journal-title":"PLoS Pathog"},{"issue":"9","key":"5768_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1097\/IAE.0000000000002919","volume":"40","author":"A Hadayer","year":"2020","unstructured":"Hadayer A, Zahavi A, Livny E, Gal-Or O, Gershoni A, Mimouni K, Ehrlich R (2020) Patients wearing face masks during intravitreal injections may be at a higher risk of endophthalmitis. Retina 40(9):1651\u20131656. https:\/\/doi.org\/10.1097\/IAE.0000000000002919","journal-title":"Retina"},{"key":"5768_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ajo.2020.10.017","volume":"223","author":"SN Patel","year":"2021","unstructured":"Patel SN, Mahmoudzadeh R, Salabati M, Soares RR, Hinkle J, Hsu J, Garg SJ, Regillo CD, Ho AC, Cohen MN, Khan MA, Yonekawa Y, Chiang A, Gupta OP, Kuriyan AE (2021) Bacterial dispersion associated with various patient face mask designs during simulated intravitreal injections. Am J Ophthalmol 223:178\u2013183. https:\/\/doi.org\/10.1016\/j.ajo.2020.10.017","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5768_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2021-000804","volume":"6","author":"S Angaramo","year":"2021","unstructured":"Angaramo S, Law JC, Maris AS, Schmitz JE, Liu Y, Chen Q, Chomsky A (2021) Potential impact of oral flora dispersal on patients wearing face masks when undergoing ophthalmologic procedures. BMJ Open Ophthalmol 6(1):e000804. https:\/\/doi.org\/10.1136\/bmjophth-2021-000804","journal-title":"BMJ Open Ophthalmol"},{"issue":"5","key":"5768_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/s-2005-858231","volume":"222","author":"GB Jaissle","year":"2005","unstructured":"Jaissle GB, Szurman P, Bartz-Schmidt KU, German Retina S, German Society of O, German Professional Association of O (2005) [Recommendation for the implementation of intravitreal injections\u2014statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)]. Klin Monbl Augenheilkd 222(5):390\u2013395. https:\/\/doi.org\/10.1055\/s-2005-858231","journal-title":"Klin Monbl Augenheilkd"},{"key":"5768_CR13","unstructured":"Bundesregierung-Deutschland (2020) Gesetz zur Verh\u00fctung und Bek\u00e4mpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG)\u00a0\u00a7 28a Besondere Schutzma\u00dfnahmen zur Verhinderung der Verbreitung der Coronavirus-Krankheit-2019 (COVID-19). https:\/\/www.gesetze-im-internet.de\/ifsg\/__28a.html . Accessed 01.01.2022"},{"issue":"10","key":"5768_CR14","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.4103\/ijo.IJO_2005_21","volume":"69","author":"SCL Au","year":"2021","unstructured":"Au SCL, Ko CKL (2021) Delayed hospital presentation of acute central retinal artery occlusion during the COVID-19 crisis: the HORA study brief report No. 4. Indian J Ophthalmol 69(10):2904\u20132905. https:\/\/doi.org\/10.4103\/ijo.IJO_2005_21","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"5768_CR15","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41433-020-1056-0","volume":"35","author":"M Awad","year":"2021","unstructured":"Awad M, Poostchi A, Orr G, Kumudhan D, Zaman A, Wilde C (2021) Delayed presentation and increased prevalence of proliferative vitreoretinopathy for primary rhegmatogenous retinal detachments presenting during the COVID-19 pandemic lockdown. Eye (Lond) 35(4):1282\u20131283. https:\/\/doi.org\/10.1038\/s41433-020-1056-0","journal-title":"Eye (Lond)"},{"issue":"10248","key":"5768_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0140-6736(20)31356-8","volume":"396","author":"MM Mafham","year":"2020","unstructured":"Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, Hollings S, Roebuck C, Gale CP, Mamas MA, Deanfield JE, de Belder MA, Luescher TF, Denwood T, Landray MJ, Emberson JR, Collins R, Morris EJA, Casadei B, Baigent C (2020) COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 396(10248):381\u2013389. https:\/\/doi.org\/10.1016\/S0140-6736(20)31356-8","journal-title":"Lancet"},{"issue":"11","key":"5768_CR17","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.ophtha.2021.05.010","volume":"128","author":"SN Patel","year":"2021","unstructured":"Writing committee for the Post-Injection Endophthalmitis Study G, Patel SN, Tang PH, Storey PP, Wolfe JD, Fein J, Shah SP, Chen E, Abbey A, Ferrone PJ, Shah CP, Liang MC, Stem MS, Ali Khan M, Yonekawa Y, Garg SJ (2021) The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections. Ophthalmology 128(11):1620\u20131626. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.010","journal-title":"Ophthalmology"},{"issue":"11","key":"5768_CR18","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/IAE.0000000000003193","volume":"41","author":"MM Naguib","year":"2021","unstructured":"Naguib MM, Ghauri S, Mukhopadhyay A, Schefler AC (2021) Endophthalmitis after intravitreal injections during the Covid-19 pandemic with implementation of universal masking. Retina 41(11):2208\u20132214. https:\/\/doi.org\/10.1097\/IAE.0000000000003193","journal-title":"Retina"},{"key":"5768_CR19","doi-asserted-by":"publisher","author":"F Lum","year":"2022","unstructured":"Lum F, Li S, Liu L, Li C, Parke DW 2nd, Williams GA (2022) The pandemic is not associated with endophthalmitis decrease after anti-vascular endothelial growth factor injections. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2022.01.009","journal-title":"Ophthalmology","DOI":"10.1016\/j.ophtha.2022.01.009"},{"issue":"10","key":"5768_CR20","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","volume":"118","author":"CP Shah","year":"2011","unstructured":"Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis Study T (2011) Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118(10):2028\u20132034. https:\/\/doi.org\/10.1016\/j.ophtha.2011.02.034","journal-title":"Ophthalmology"},{"issue":"1","key":"5768_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.oret.2018.09.013","volume":"3","author":"MS Stem","year":"2019","unstructured":"Stem MS, Rao P, Lee IJ, Woodward MA, Faia LJ, Wolfe JD, Capone A Jr, Covert D, Dass AB, Drenser KA, Garretson BR, Hassan TS, Margherio A, Oh KT, Raephaelian PV, Randhawa S, Sneed S, Trese MT, Yedavally S, Williams GA, Ruby AJ (2019) Predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength. Ophthalmol Retina 3(1):3\u20137. https:\/\/doi.org\/10.1016\/j.oret.2018.09.013","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"5768_CR22","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/eye.2012.199","volume":"26","author":"DA Lyall","year":"2012","unstructured":"Lyall DA, Tey A, Foot B, Roxburgh ST, Virdi M, Robertson C, MacEwen CJ (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 26(12):1517\u20131526. https:\/\/doi.org\/10.1038\/eye.2012.199","journal-title":"Eye (Lond)"},{"issue":"2","key":"5768_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5455\/medarh.2021.75.144-148","volume":"75","author":"I Krolo","year":"2021","unstructured":"Krolo I, Blazeka M, Merdzo I, Vrtar I, Sabol I, Petric-Vickovic I (2021) Mask-associated dry eye during COVID-19 pandemic\u2014how face masks contribute to dry eye disease symptoms. Med Arch 75(2):144\u2013148. https:\/\/doi.org\/10.5455\/medarh.2021.75.144-148","journal-title":"Med Arch"},{"issue":"1","key":"5768_CR24","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1038\/s41598-020-68952-w","volume":"10","author":"KA Willis","year":"2020","unstructured":"Willis KA, Postnikoff CK, Freeman A, Rezonzew G, Nichols K, Gaggar A, Lal CV (2020) The closed eye harbours a unique microbiome in dry eye disease. Sci Rep 10(1):12035. https:\/\/doi.org\/10.1038\/s41598-020-68952-w","journal-title":"Sci Rep"},{"key":"5768_CR25","doi-asserted-by":"publisher","unstructured":"Petrillo F, Pignataro D, Lavano MA, Santella B, Folliero V, Zannella C, Astarita C, Gagliano C, Franci G, Avitabile T, Galdiero M (2020) Current evidence on the ocular surface microbiota and related diseases. Microorganisms 8(7). https:\/\/doi.org\/10.3390\/microorganisms8071033","DOI":"10.3390\/microorganisms8071033"},{"key":"5768_CR26","doi-asserted-by":"publisher","author":"K Blom","year":"2021","unstructured":"Blom K, Bragadottir R, Sivertsen MS, Moe MC, Jorstad OK (2021) Mask use by patients in the context of COVID-19 can increase the risk of postinjection endophthalmitis. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.14945","journal-title":"Acta Ophthalmol","DOI":"10.1111\/aos.14945"},{"key":"5768_CR27","unstructured":"Statista (2021) How often have you worn a face mask outside your home to protect yourself or others from coronavirus (COVID-19)? . https:\/\/www.statista.com\/statistics\/1114375\/wearing-a-face-mask-outside-in-european-countries\/. Accessed 01.01.2022"},{"key":"5768_CR28","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.2147\/OPTH.S327745","volume":"15","author":"FC Kortuem","year":"2021","unstructured":"Kortuem FC, Ziemssen F, Kortuem KU, Kortuem C (2021) The role and views of ophthalmologists during the COVID-19 pandemic. Clin Ophthalmol 15:3947\u20133956. https:\/\/doi.org\/10.2147\/OPTH.S327745","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"5768_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1097\/IAE.0000000000003202","volume":"41","author":"J Marin-Nieto","year":"2021","unstructured":"Marin-Nieto J, Reino-Perez C, Santillana-Cernuda G, Diaz-Bernal JM, Luque-Aranda R, Garcia-Basterra I (2021) Face mask contamination during Covid-19 pandemia. A study on patients receiving intravitreal injections. Retina 41(11):2215\u20132220. https:\/\/doi.org\/10.1097\/IAE.0000000000003202","journal-title":"Retina"},{"key":"5768_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jth.2021.101078","volume":"21","author":"A Guellich","year":"2021","unstructured":"Guellich A, Tella E, Ariane M, Grodner C, Nguyen-Chi HN, Mahe E (2021) The face mask-touching behavior during the COVID-19 pandemic: observational study of public transportation users in the greater Paris region: the French-mask-touch study. J Transp Health 21:101078. https:\/\/doi.org\/10.1016\/j.jth.2021.101078","journal-title":"J Transp Health"},{"key":"5768_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.732047","volume":"8","author":"L Delanghe","year":"2021","unstructured":"Delanghe L, Cauwenberghs E, Spacova I, De Boeck I, Van Beeck W, Pepermans K, Claes I, Vandenheuvel D, Verhoeven V, Lebeer S (2021) Cotton and surgical face masks in community settings: bacterial contamination and face mask hygiene. Front Med (Lausanne) 8:732047. https:\/\/doi.org\/10.3389\/fmed.2021.732047","journal-title":"Front Med (Lausanne)"},{"key":"5768_CR32","doi-asserted-by":"publisher","unstructured":"Allison ALA-DE, Bawn M, Casas Arredondo M, Chau C, Chandler K et al (2021) The impact and effectiveness of the general public wearing masks to reduce the spread of pandemics in the UK: a multidisciplinary comparison of single-use masks versus reusable face masks. UCL Open Environ 3(01). https:\/\/doi.org\/10.14324\/111.444\/ucloe.000022","DOI":"10.14324\/111.444\/ucloe.000022"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05768-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T03:04:38Z","timestamp":1672455878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["5768"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00417-022-05768-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":["Cellular and Molecular Neuroscience","Sensory Systems","Ophthalmology"],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"15 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the tenets of the Declaration of Helsinki and was approved by the institutional ethics committee (Project Number 145\/2022BO2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"F. Z.: Consultant: Alimera Sciences, Allergan\/Abbvie, Bayer, Boehringer-Ingelheim, Novartis, NovoNordisk, MSD, Oxurion, Roche\/Genentech; Speaker: Alimera, Allergan\/Abbvie, Bayer, BDI, CME Health, Gerling, Novartis, ODOS, Roche, Research: Bayer, BMBF, Clearside, DFG, Kodiak, Iveric, Ophtea, Novartis, Regeneron. All other authors declare they have no financial or direct\/indirect competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}} |